{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:19:55Z","timestamp":1790363995372,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02773-x","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:23:42Z","timestamp":1747826622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)"],"prefix":"10.1186","volume":"24","author":[{"given":"Pasquale","family":"Paolisso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Gallinoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Scarsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Portolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Armillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Moscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Montalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elayne Kelen","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Orzalkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Fabroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verdiana","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurcan","family":"Baydaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Policastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ausiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giose","family":"Vincelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Casenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Scisciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Ielasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Andreini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo Andrea","family":"Oreglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Bartorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Palmerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangela","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vanderheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2773_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375:323\u201334.","journal-title":"N Engl J Med"},{"key":"2773_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644\u201357.","journal-title":"N Engl J Med"},{"key":"2773_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:347\u201357.","journal-title":"N Engl J Med"},{"key":"2773_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295\u2013306.","journal-title":"N Engl J Med"},{"key":"2773_CR5","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346.","journal-title":"N Engl J Med"},{"key":"2773_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ejhf.3145","volume":"26","author":"L Scisciola","year":"2024","unstructured":"Scisciola L, Paolisso P, Belmonte M, et al. Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: the BIO-AS study. Eur J Heart Fail. 2024;26:471\u201382.","journal-title":"Eur J Heart Fail"},{"key":"2773_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12933-024-02504-8","volume":"23","author":"P Paolisso","year":"2024","unstructured":"Paolisso P, Belmonte M, Gallinoro E, et al. SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI). Cardiovasc Diabetol. 2024;23:420.","journal-title":"Cardiovasc Diabetol"},{"key":"2773_CR8","doi-asserted-by":"crossref","unstructured":"Shah T, Zhang Z, Shah H et al. Effect of sodium-glucose cotransporter-2 inhibitors on the progression of aortic stenosis. JACC Cardiovasc Interv 2025.","DOI":"10.1016\/j.jcin.2024.11.036"},{"key":"2773_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/eurheartj\/ehp552","volume":"31","author":"R Bagur","year":"2009","unstructured":"Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2009;31:865\u201374.","journal-title":"Eur Heart J"},{"key":"2773_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ccd.25867","volume":"86","author":"G Gargiulo","year":"2015","unstructured":"Gargiulo G, Sannino A, Capodanno D, et al. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: a meta-analysis of 5,971 patients. Catheter Cardiovasc Interv. 2015;86:518\u201327.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2773_CR11","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","volume":"77","author":"P G\u00e9n\u00e9reux","year":"2021","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC, et al. Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol. 2021;77:2717\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"2773_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4244\/EIJV10I1A20","volume":"10","author":"M Barbanti","year":"2014","unstructured":"Barbanti M, Latib A, Sgroi C, et al. Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project. EuroIntervention. 2014;10:133\u201340.","journal-title":"EuroIntervention"},{"key":"2773_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/FJC.0000000000001329","volume":"80","author":"A Nusca","year":"2022","unstructured":"Nusca A, Piccirillo F, Viscusi MM, et al. Contrast-induced acute kidney injury in diabetic patients and SGLT-2 inhibitors: a preventive opportunity or promoting element? J Cardiovasc Pharmacol. 2022;80:661\u201371.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2773_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561\u2013632.","journal-title":"Eur Heart J"},{"key":"2773_CR15","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/ehjci\/jead153","volume":"24","author":"MR Dweck","year":"2023","unstructured":"Dweck MR, Loganath K, Bing R, et al. Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document. Eur Heart J Cardiovasc Imaging. 2023;24:1430\u201343.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2773_CR16","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","volume":"38","author":"P G\u00e9n\u00e9reux","year":"2017","unstructured":"G\u00e9n\u00e9reux P, Pibarot P, Redfors B, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38:3351\u20138.","journal-title":"Eur Heart J"},{"key":"2773_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","volume":"102","author":"P Rossing","year":"2022","unstructured":"Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102:990\u20139.","journal-title":"Kidney Int"},{"key":"2773_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, et al. 2017 Cardiovascular and stroke endpoint definitions for clinical trials. Circulation. 2018;137:961\u201372.","journal-title":"Circulation"},{"key":"2773_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031019","volume":"13","author":"JK Petersen","year":"2024","unstructured":"Petersen JK, \u00d8stergaard L, Carlson N, et al. Impact of acute kidney injury after transcatheter aortic valve replacement: a nationwide study. J Am Heart Assoc. 2024;13: e031019.","journal-title":"J Am Heart Assoc"},{"key":"2773_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110766","volume":"202","author":"P Paolisso","year":"2023","unstructured":"Paolisso P, Bergamaschi L, Cesaro A, et al. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: insight from SGLT2-I AMI PROTECT registry. Diabetes Res Clin Pract. 2023;202: 110766.","journal-title":"Diabetes Res Clin Pract"},{"key":"2773_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4244\/EIJV8I5A87","volume":"8","author":"MZ Khawaja","year":"2012","unstructured":"Khawaja MZ, Thomas M, Joshi A, et al. The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention. 2012;8:563\u201370.","journal-title":"EuroIntervention"},{"key":"2773_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12933-022-01654-x","volume":"21","author":"AC van Nieuwkerk","year":"2022","unstructured":"van Nieuwkerk AC, Santos RB, Mata RB, et al. Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis. Cardiovasc Diabetol. 2022;21:246.","journal-title":"Cardiovasc Diabetol"},{"key":"2773_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cjca.2023.11.010","volume":"40","author":"M Belmonte","year":"2024","unstructured":"Belmonte M, Paolisso P, Bertolone DT, et al. Combined cardiac damage staging by echocardiography and cardiac catheterization in patients with clinically significant aortic stenosis. Can J Cardiol. 2024;40:643\u201354.","journal-title":"Can J Cardiol"},{"key":"2773_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.100959","volume":"3","author":"OM Abdelfattah","year":"2024","unstructured":"Abdelfattah OM, Jacquemyn X, S\u00e1 MP, et al. Cardiac damage staging predicts outcomes in aortic valve stenosis after aortic valve replacement: meta-analysis. JACC Adv. 2024;3: 100959.","journal-title":"JACC Adv"},{"key":"2773_CR25","doi-asserted-by":"crossref","unstructured":"Belmonte M, Paolisso P, de Oliveira EK et al. Association of Cardiac Damage and Computed Tomography-Derived Extracellular Volume in Patients Undergoing Transcatheter Aortic Valve Implantation. Can J Cardiol 2025.","DOI":"10.1016\/j.cjca.2025.02.031"},{"key":"2773_CR26","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.4244\/EIJ-D-15-00254","volume":"12","author":"YB Liao","year":"2017","unstructured":"Liao YB, Deng XX, Meng Y, et al. Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis. EuroIntervention. 2017;12:2067\u201374.","journal-title":"EuroIntervention"},{"key":"2773_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacc.2022.11.050","volume":"81","author":"M Avvedimento","year":"2023","unstructured":"Avvedimento M, Nuche J, Farjat-Pasos JI, Rod\u00e9s-Cabau J. Bleeding events after transcatheter aortic valve replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023;81:684\u2013702.","journal-title":"J Am Coll Cardiol"},{"key":"2773_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108861","volume":"270","author":"M Armillotta","year":"2025","unstructured":"Armillotta M, Angeli F, Paolisso P, et al. Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure. Pharmacol Ther. 2025;270: 108861.","journal-title":"Pharmacol Ther"},{"key":"2773_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","volume":"97","author":"EJM van Bommel","year":"2020","unstructured":"van Bommel EJM, Muskiet MHA, van Baar MJB, et al. The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial. Kidney Int. 2020;97:202\u201312.","journal-title":"Kidney Int"},{"key":"2773_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106659","volume":"188","author":"K Urbanek","year":"2023","unstructured":"Urbanek K, Cappetta D, Bellocchio G, et al. Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome. Pharmacol Res. 2023;188: 106659.","journal-title":"Pharmacol Res"},{"key":"2773_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00228-024-03799-y","volume":"81","author":"G Fan","year":"2025","unstructured":"Fan G, Lin L, Zuo H, Yan R, Xu C. Sodium-glucose cotransporter 2 inhibitors and contrast-induced nephropathy risk: a meta-analysis. Eur J Clin Pharmacol. 2025;81:337\u201345.","journal-title":"Eur J Clin Pharmacol"},{"key":"2773_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjcard.2025.01.007","volume":"240","author":"A Nusca","year":"2025","unstructured":"Nusca A, Di Bitonto MP, Span\u00f2 A, et al. Effects of novel antidiabetic agents on contrast-associated acute kidney injury in diabetic patients undergoing percutaneous coronary intervention. Am J Cardiol. 2025;240:50\u20136.","journal-title":"Am J Cardiol"},{"key":"2773_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-025-02678-9","volume":"24","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Zheng N, Zhang T, et al. Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study. Cardiovasc Diabetol. 2025;24:185.","journal-title":"Cardiovasc Diabetol"},{"key":"2773_CR34","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jcin.2015.07.012","volume":"8","author":"M Barbanti","year":"2015","unstructured":"Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement: the PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv. 2015;8:1595\u2013604.","journal-title":"JACC Cardiovasc Interv"},{"key":"2773_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12933-022-01508-6","volume":"21","author":"Y Suzuki","year":"2022","unstructured":"Suzuki Y, Kaneko H, Okada A, et al. Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus. Cardiovasc Diabetol. 2022;21:67.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02773-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:23:45Z","timestamp":1747826625000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2773"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02773-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted according to the principles of the Declaration of Helsinki; all patients were informed about their participation in the registry and provided informed consent for the anonymous publication of scientific data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"E.B. is the guarantor of the research and, as such, had full access to all the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of guarantor"}},{"value":"The authors do hereby declare that all illustrations and figures in the manuscript are entirely original and do not require reprint permission.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permissions Information"}}],"article-number":"221"}}